|
06/07/2023 |
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
CIGB |
Registered |
|
21/06/2023 |
VSSPs in renal carcinoma. |
CIM |
Registered |
|
19/05/2023 |
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects |
FINLAY |
Registered |
|
24/04/2023 |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
CBQ |
Registered |
|
24/04/2023 |
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
CIGB |
Registered |
|
17/04/2023 |
Dietzia safety study |
HHA |
Registered |
|
27/03/2023 |
Effect and safety of the use of Viusid® on the quality of life of patients with Chronic Kidney Disease on Hemodialysis. |
CATALYSIS |
Registered |
|
15/03/2023 |
Evaluation of the effectiveness of video games for attention intervention in school age boys and girls |
CNEURO |
Registered |
|
03/03/2023 |
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
CIM |
Registered |
|
03/03/2023 |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
CATALYSIS |
Registered |
|
09/02/2023 |
PROCTOKINASE in acute pelvic inflammatory disease |
UCMM |
Registered |
|
30/01/2023 |
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
DIRECCION DE INVESTIGACION UCE |
Registered |
|
06/01/2023 |
IVD in colon cancer |
HHA |
Registered |
|
06/12/2022 |
Prebiotics and probiotics in the treatment of type 2 diabetes |
HHA |
Registered |
|
06/12/2022 |
Nasal recombinant human interferon alfa-2b in ARI |
CIGB |
Registered |
|
14/10/2022 |
Jusvinza in Severe Patients with Acquired Community Pneumonia |
CIGB |
Registered |
|
22/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
CIM |
Registered |
|
20/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease |
CIM |
Registered |
|
30/08/2022 |
Sinopharm-SOBERANA COVID-Cienfuegos |
FINLAY |
Registered |
|
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
